Tangen wins contract re candida auris
Tangen Biosciences has been awarded a contract to develop a point-of-care device for detection of Candida auris, a “superbug” that is resistant to anti-fungal drugs and...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Tangen Biosciences has been awarded a contract to develop a point-of-care device for detection of Candida auris, a “superbug” that is resistant to anti-fungal drugs and...
A Yale University spin-off announced $25 million in new funding Wednesday, with plans to design proteins that would defeat “decoy” cells in the body that...
University of Connecticut researcher Dr. George Wu recently published a paper outlining his successful experiment delivering mitochondria to liver cells. This marks the first time researchers...
SpringWorks Therapeutics reports that the first patient has been dosed in a Phase 1b clinical trial evaluating the company’s investigational gamma secretase inhibitor, nirogacestat, in combination with...
Millions of patients around the world are suffering from the dramatic effects of fibrotic diseases. Whether the damage occurs in the liver, as in non-alcoholic...
Federal regulators have green-lighted Guilford’s AI Therapeutics to begin a clinical trial to test if its experimental drug for non-Hodgkin lymphoma and ALS could also...
AlloMek Therapeutics is a privately held company focused on developing macrocycles for treating rare diseases. AlloMek’s most advance candidate, CIP-137401, is an IND ready molecule...
Two University of Connecticut Health researchers will investigate the regulators of a cell type that plays a critical role in metabolic diseases associated with obesity....
Azitra reports that the FDA has granted Rare Pediatric Disease Designation to ATR-12 for the treatment of Netherton syndrome, a chronic genetic skin disease that can...
Giovanni Caforio, chairman and CEO of Bristol Myers Squibb, was recently interviewed in Fortune: “If there is any good news coming out of the coronavirus pandemic, it’s...